New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer

Published:2024-07-23 Issue:15 Volume:67 Page:12984-13018
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zajec Živa¹,Dernovšek Jaka¹,Cingl Jernej¹,Ogris Iza²^ORCID,Gedgaudas Marius³,Zubrienė Asta³,Mitrović Ana¹⁴,Golič Grdadolnik Simona²^ORCID,Gobec Martina¹,Tomašič Tihomir¹^ORCID

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia

2. Laboratory for Molecular Structural Dynamics, Theory Department, National Institute of Chemistry, Hajdrihova 19, 1001 Ljubljana, Slovenia

3. Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, LT-10257 Vilnius, Lithuania

4. Department of Biotechnology, Jožef Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia

Funder

Ministrstvo za Izobra?evanje, Znanost in ?port

Javna Agencija za Raziskovalno Dejavnost RS

European Regional Development Fund

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00932

Reference68 articles.

1. Breast cancer

2. Recent Advances in the Treatment of Breast Cancer

3. Treatment of Breast Cancer

4. Breast Cancer Treatment

5. Breast cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP